Search

Displaying all 4 results
  1. Indication

    CLDN 18.2-positive unresectable, locally advanced HER2 negative Gastric Adenocarcinoma

    go.drugbank.com/conditions/DBCOND0171117
    Drugs: Zolbetuximab
  2. Indication

    CLDN 18.2-positive unresectable, locally advanced HER2 negative Gastroesophageal Junction Adenocarcinoma

    go.drugbank.com/conditions/DBCOND0171122
    Drugs: Zolbetuximab
  3. Indication

    CLDN 18.2-positive metastatic HER2 negative Gastric Adenocarcinoma

    go.drugbank.com/conditions/DBCOND0171119
    Drugs: Zolbetuximab
  4. Indication

    CLDN 18.2-positive metastatic HER2 negative Gastroesophageal Junction Adenocarcinoma

    go.drugbank.com/conditions/DBCOND0171124
    Drugs: Zolbetuximab